How Do I Fight a Charge for a Prescription Drug DUI?

Answer:

Fighting a prescription drug DUI in Georgia requires understanding how the statute differs from a standard alcohol DUI. Under O.C.G.A. § 40-6-391(a)(4), the state must prove the drug rendered the driver incapable of driving safely — a higher and more specific standard than the less safe driver formulation used in alcohol cases. Unlike alcohol, most prescription medications have no universally accepted blood concentration threshold above which impairment is legally presumed, so the prosecution cannot rely on a simple number. Defense strategies include retaining a toxicologist or pharmacologist to challenge whether the detected concentration was within the normal therapeutic range, challenging the Drug Recognition Expert’s evaluation and certification, attacking the reliability of field sobriety tests for drug impairment, and presenting the defendant’s lawful, physician-directed medication use as compelling context for the jury. Prescription drug DUI is one of the categories most amenable to trial defense in Georgia.

Being charged with DUI while taking medication that a licensed physician has legally prescribed to you is one of the more nuanced and potentially defensible scenarios in Georgia DUI law. While the fact that a drug is prescribed does not exempt a driver from prosecution, the specific statutory language governing these cases creates meaningful differences from a standard alcohol DUI — differences that a knowledgeable defense attorney can leverage effectively.

The Statutory Framework for Prescription Drug DUI

Georgia’s DUI statute, O.C.G.A. § 40-6-391(a)(4), addresses driving under the influence of any drug that renders the driver incapable of driving safely. For legally prescribed medications, O.C.G.A. § 40-6-391(b) provides a specific carve-out: a person who is taking a drug prescribed by a licensed physician and is under the influence of that drug to a degree that renders them incapable of driving safely may be convicted. The critical language — renders incapable of driving safely — sets a higher and more specific bar than the standard less safe driver formulation used in alcohol DUI prosecutions.

This statutory distinction is not merely semantic. In practice, courts have interpreted incapable of driving safely as substantially equivalent to the less safe standard, but the language itself remains a powerful tool in trial advocacy. The word incapable connotes an inability to drive — not simply a diminished ability. When arguing a prescription drug DUI case to a jury, defense counsel can frame the prosecution’s burden around this language: the state must prove not merely that the medication affected the defendant’s driving, but that it rendered them altogether incapable of safe operation.

Why Prescription Drug DUI Cases Are Distinct

In a standard DUI case involving alcohol, the prosecution benefits from widely understood social and legal norms around intoxication, easily communicated BAC numbers, and a body of research linking BAC levels to impairment. Prescription drug DUI cases lack these advantages for the prosecution. There is no universally accepted blood concentration threshold for most prescription medications above which impairment can be scientifically presumed, and the relationship between blood concentration and actual driving impairment is far more complex and individualized for medications than for alcohol.

Moreover, a defendant taking medication as prescribed by a physician is, as a matter of common experience, doing something entirely lawful and responsible. The jury is likely to recognize that millions of people take prescription medications daily while functioning fully and safely. This reality — that the defendant was simply following their doctor’s orders — is a narrative that resonates with jurors and can be framed sympathetically when the evidence supports it.

Challenging the Evidence of Incapability

The prosecution in a prescription drug DUI case must prove that the specific medication caused the driver to be incapable of driving safely. This requires more than establishing that the drug was in the driver’s system — it requires connecting the drug’s presence to the driver’s actual impaired operation of the vehicle. Defense strategies include challenging the reliability and relevance of any blood or urine test results, particularly when the concentration detected is within the therapeutic range that patients routinely maintain without impairment.

Defense counsel should retain a toxicologist or pharmacologist to provide expert testimony on the specific medication involved, its known effects at the detected concentration, the expected variation in individual response to the drug, and whether the detected concentration is consistent with normal therapeutic use. If the prosecution’s own expert cannot establish that the concentration found in the defendant’s system is associated with impairment rather than normal medication management, the incapability element is genuinely disputed.

The Role of the Drug Recognition Expert

Law enforcement frequently deploys Drug Recognition Experts (DREs) in prescription drug DUI investigations. A DRE is an officer trained in a 12-step evaluation protocol developed by the International Association of Chiefs of Police and adopted by the National Highway Traffic Safety Administration. The DRE protocol is designed to identify drug impairment and categorize the type of drug causing the impairment.

DRE evaluations are subject to challenge on multiple grounds. The foundational research validating the DRE protocol has been criticized in peer-reviewed literature for methodological weaknesses. The officer conducting the evaluation must be certified and must strictly follow the protocol — deviations from the prescribed procedure can be identified through careful review of the evaluation paperwork and video evidence. Expert testimony challenging the DRE’s conclusions is well-established in criminal defense practice and can effectively rebut the prosecution’s impairment narrative.

Field Sobriety Tests in Prescription Drug Cases

Standard field sobriety tests — the Walk-and-Turn, One-Leg Stand, and Horizontal Gaze Nystagmus — were developed and validated for detecting alcohol impairment. Their reliability as indicators of impairment caused by prescription medications is significantly lower, particularly for drugs that do not affect the ocular motor system in the same way that alcohol does. A defendant whose performance on field sobriety tests was affected by a medical condition, advanced age, fatigue, or physical limitation rather than drug impairment has a strong argument that the test results cannot support an inference of incapability.

Practical Defense Considerations

Anyone charged with a prescription drug DUI in Georgia should gather all records related to the prescribed medication, including the prescription itself, pharmacy records, the prescribing physician’s documentation of the treatment and dosage instructions, and any medical records that bear on the condition being treated and the expected effects of the medication. This documentation is foundational to the defense and supports the argument that the defendant was in compliance with their prescribed regimen.

The incapable of driving safely standard, combined with the absence of a recognized per se concentration threshold for most prescription medications, makes prescription drug DUI one of the categories of DUI cases in Georgia most amenable to trial defense. Early retention of defense counsel and engagement of appropriate expert witnesses are the most important steps a defendant can take.